Equitable Trust Co. Has $336,000 Stock Position in Lam Research Corporation $LRCX

Equitable Trust Co. lowered its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 24.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,449 shares of the semiconductor company’s stock after selling 1,125 shares during the period. Equitable Trust Co.’s holdings in Lam Research were worth $336,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in LRCX. BankPlus Wealth Management LLC grew its holdings in shares of Lam Research by 2.0% during the 2nd quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company’s stock valued at $511,000 after purchasing an additional 105 shares during the last quarter. ORG Partners LLC grew its holdings in shares of Lam Research by 7.3% during the 2nd quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company’s stock valued at $162,000 after purchasing an additional 114 shares during the last quarter. Fairvoy Private Wealth LLC grew its holdings in shares of Lam Research by 3.0% during the 2nd quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company’s stock valued at $407,000 after purchasing an additional 120 shares during the last quarter. Abundance Wealth Counselors grew its holdings in shares of Lam Research by 1.1% during the 2nd quarter. Abundance Wealth Counselors now owns 11,537 shares of the semiconductor company’s stock valued at $1,123,000 after purchasing an additional 124 shares during the last quarter. Finally, First Pacific Financial grew its holdings in shares of Lam Research by 7.7% during the 2nd quarter. First Pacific Financial now owns 1,766 shares of the semiconductor company’s stock valued at $172,000 after purchasing an additional 126 shares during the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Trading Up 4.7%

Shares of NASDAQ LRCX opened at $144.78 on Thursday. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $153.70. The stock has a market cap of $182.57 billion, a P/E ratio of 34.80, a price-to-earnings-growth ratio of 1.68 and a beta of 1.84. The firm has a 50-day moving average of $117.40 and a 200 day moving average of $95.82. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.12. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The company had revenue of $5.17 billion during the quarter, compared to analysts’ expectations of $4.99 billion. During the same period last year, the company posted $1.03 EPS. Lam Research’s revenue was up 33.6% on a year-over-year basis. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were given a dividend of $0.26 per share. This is an increase from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Wednesday, September 24th. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. Lam Research’s dividend payout ratio is 25.00%.

Analyst Upgrades and Downgrades

LRCX has been the topic of several recent research reports. Needham & Company LLC increased their target price on shares of Lam Research from $110.00 to $115.00 and gave the company a “buy” rating in a report on Thursday, July 31st. Stifel Nicolaus set a $135.00 target price on shares of Lam Research and gave the company a “buy” rating in a report on Monday. Argus raised their price target on shares of Lam Research from $105.00 to $120.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Wall Street Zen raised shares of Lam Research from a “hold” rating to a “buy” rating in a report on Saturday, October 4th. Finally, Erste Group Bank assumed coverage on shares of Lam Research in a report on Thursday, August 14th. They issued a “buy” rating on the stock. Twenty-three investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $123.80.

Insider Transactions at Lam Research

In related news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.31% of the stock is currently owned by company insiders.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.